Risk of Worsening Asthma From LAIV Unfounded
A new study found no risks for exacerbation of asthma in children given LAIV, despite ACIP recommendations against its use in children with asthma.
A new study found no risks for exacerbation of asthma in children given LAIV, despite ACIP recommendations against its use in children with asthma.
The inactivated monovalent influenza A(H1N1) vacccines in both adjuvanted and unadjuvanted forms were more effective in children than adults.
In the guidance documents, the FDA advised against using any marketing language that may be “misleading” or has potential to cause patient harm.
The live attenuated influenza vaccine, LAIV, is safe in children under 2 with underlying medical conditions.
Lung ultrasounds present an effective alternative to diagnosing pneumonia.